Pfizer COVID-19 Vaccine Elicits Lower Antibody Levels In Older Adults Compared To Younger Adults, Research Shows

Healio (9/24, Downey) reported, “The Pfizer-BioNTech COVID-19 vaccine elicited ‘relatively lower’ antibody levels in adults aged 50 years or older than in adults aged younger than 50 years, researchers reported in JAMA Network Open.” Researchers “conducte...